Home › Compare › EMMLF vs MCD

EMMLF vs MCD: Dividend Comparison 2026

EMMLF yields 14598.54% · MCD yields 2.35%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 EMMLF wins by $2315127447129181184.00M in total portfolio value
10 years
EMMLF
EMMLF
● Live price
14598.54%
Share price
$0.01
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$2315127447129181184.00M
Annual income
$2,284,345,916,069,374,600,000,000.00
Full EMMLF calculator →
MCD
McDonald's Corporation
● Live price
2.35%
Share price
$308.53
Annual div
$7.26
5Y div CAGR
42.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$78.5K
Annual income
$26,227.70
Full MCD calculator →

Portfolio growth — EMMLF vs MCD

📍 EMMLF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodEMMLFMCD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, EMMLF + MCD cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
EMMLF pays
MCD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

EMMLF
Annual income on $10K today (after 15% tax)
$1,240,875.91/yr
After 10yr DRIP, annual income (after tax)
$1,941,694,028,658,968,500,000,000.00/yr
MCD
Annual income on $10K today (after 15% tax)
$200.01/yr
After 10yr DRIP, annual income (after tax)
$22,293.55/yr
At 15% tax rate, EMMLF beats the other by $1,941,694,028,658,968,500,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of EMMLF + MCD for your $10,000?

EMMLF: 50%MCD: 50%
100% MCD50/50100% EMMLF
Portfolio after 10yr
$1157563723564590592.00M
Annual income
$1,142,172,958,034,687,300,000,000.00/yr
Blended yield
98.67%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MCD right now

EMMLF
No analyst data
MCD
Analyst Ratings
37
Buy
23
Hold
1
Sell
Consensus: Buy
Price Target
$351.76
+14.0% upside vs current
Range: $320.00 — $385.00
Altman Z
4.9
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

EMMLF buys
0
MCD buys
0
No recent congressional trades found for EMMLF or MCD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricEMMLFMCD
Forward yield14598.54% ✓2.35%
Annual dividend / share$2.00$7.26 ✓
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%42.3% ✓
Portfolio after 10y$2315127447129181184.00M ✓$78.5K
Annual income after 10y$2,284,345,916,069,374,600,000,000.00 ✓$26,227.70
Total dividends collected$2313090038871241728.00M ✓$58.5K
Payment frequencyquarterlyquarterly
SectorStockConsumer Discretionary

Year-by-year: EMMLF vs MCD ($10,000, DRIP)

YearEMMLF PortfolioEMMLF Income/yrMCD PortfolioMCD Income/yrGap
1← crossover$1,470,554$1,459,854.01$10,815$334.85+$1.46M → EMMLF
2$202,208,463$200,634,970.27$11,826$491.71+$202.20M → EMMLF
3$25,999,823,322$25,783,460,266.67$13,123$730.06+$25999.81M → EMMLF
4$3,126,155,661,671$3,098,335,850,716.16$14,853$1,100.07+$3126155.65M → EMMLF
5$351,509,831,288,492$348,164,844,730,504.60$17,257$1,690.61+$351509831.27M → EMMLF
6$36,963,217,951,789,784$36,587,102,432,311,096.00$20,752$2,667.01+$36963217951.77M → EMMLF
7$3,635,193,394,947,107,000$3,595,642,751,738,691,600.00$26,103$4,354.83+$3635193394947.08M → EMMLF
8$334,373,707,794,473,750,000$330,484,050,861,880,400,000.00$34,794$7,437.78+$334373707794473.69M → EMMLF
9$28,767,786,037,201,900,000,000$28,410,006,169,861,807,000,000.00$49,926$13,461.60+$28767786037201900.00M → EMMLF
10$2,315,127,447,129,181,000,000,000$2,284,345,916,069,374,600,000,000.00$78,550$26,227.70+$2315127447129181184.00M → EMMLF

EMMLF vs MCD: Complete Analysis 2026

EMMLF — Stock

OKYO Pharma Limited, a preclinical biopharmaceutical company, engages in developing therapeutics for patients suffering from inflammatory eye diseases and ocular pain in the United Kingdom. Its lead product includes OK-101 for the treatment of dry eye disease. The company is also developing OK-201, a bovine adrenal medulla, lipidated-peptide preclinical analogue candidate for the treatment of neuropathic ocular pain. OKYO Pharma Limited was incorporated in 2007 and is headquartered in London, the United Kingdom.

Full EMMLF Calculator →

MCD — Consumer Discretionary

McDonald's Corporation operates and franchises McDonald's restaurants in the United States and internationally. Its restaurants offer hamburgers and cheeseburgers, chicken sandwiches and nuggets, wraps, fries, salads, oatmeal, shakes, desserts, sundaes, soft serve cones, bakery items, soft drinks, coffee, and beverages and other beverages, as well as breakfast menu, including biscuit and bagel sandwiches, breakfast burritos, hotcakes, and other sandwiches. As of December 31, 2021, the company operated 40,031 restaurants. McDonald's Corporation was founded in 1940 and is headquartered in Chicago, Illinois.

Full MCD Calculator →
📬

Get this EMMLF vs MCD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

EMMLF vs SCHDEMMLF vs JEPIEMMLF vs OEMMLF vs KOEMMLF vs MAINEMMLF vs YUMEMMLF vs QSREMMLF vs SBUX

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.